In Brief: Gull Laboratories
This article was originally published in The Gray Sheet
Gull Laboratories: Milton Adair, president and CEO of the Salt Lake City-based infectious disease and autoimmune diagnostic test kit manufacturer, steps down from his post due to "differences in business strategies" with the firm's board. Ernest Sumsion, Gull's vice president of technical marketing, will serve as interim president while the company conducts a search for a replacement...
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
Stada has appointed a head of digital communications; PGEU elects new chair and vice-chair; and the new UK health claims committee unveils its first members.